OncoSil Medical Ltd (OSL.AX)
OncoSil Medical Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Macquarie Park, NSW, AU. The stock last traded at $1.30, down 0.38% on the session, giving a market capitalisation of $40.2M. Its beta of 1.23 implies it has historically moved more than the broad market.
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
OncoSil Medical Ltd is most often compared with the following Healthcare names: